These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38495452)

  • 21. Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study.
    Alavi M; Janjua NZ; Chong M; Grebely J; Aspinall EJ; Innes H; Valerio H; Hajarizadeh B; Hayes PC; Krajden M; Amin J; Law MG; George J; Goldberg DJ; Hutchinson SJ; Dore GJ
    J Viral Hepat; 2018 May; 25(5):473-481. PubMed ID: 29194861
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment Patterns and Health Resource Utilization in Patients With Hepatocellular Carcinoma After Failure of Sorafenib in Real-World Setting in Taiwan.
    Novick D; Rajan N; Wei A; Cheng R; Szende A; Baik R; Colman S
    Value Health Reg Issues; 2022 Jul; 30():76-82. PubMed ID: 35278836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation.
    Walton M; Wade R; Claxton L; Sharif-Hurst S; Harden M; Patel J; Rowe I; Hodgson R; Eastwood A
    Health Technol Assess; 2020 Sep; 24(48):1-264. PubMed ID: 33001024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma.
    Asemota J; Saleh M; Igbinovia O; Burns D
    Cureus; 2020 Jul; 12(7):e9191. PubMed ID: 32818122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of a computable phenotype to identify a transgender sample for health research purposes: a feasibility study in a large linked provincial healthcare administrative cohort in British Columbia, Canada.
    Rich AJ; Poteat T; Koehoorn M; Li J; Ye M; Sereda P; Salway T; Hogg R
    BMJ Open; 2021 Mar; 11(3):e040928. PubMed ID: 33766836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic Implications of Hepatocellular Carcinoma Surveillance and Treatment: A Guide for Clinicians.
    Likhitsup A; Parikh ND
    Pharmacoeconomics; 2020 Jan; 38(1):5-24. PubMed ID: 31573053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of guideline adherence on the prognosis of Barcelona clinic liver cancer stage B hepatocellular carcinoma.
    Han JE; Cho HJ; Cheong JY; Lim SG; Yang MJ; Noh CK; Lee GH; Kim SS
    World J Gastroenterol; 2023 Dec; 29(47):6122-6137. PubMed ID: 38186683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Impact of Suboxone's Market Exclusivity on Cost of Opioid Use Disorder Treatment.
    McGee M; Chiu K; Moineddin R; Sud A
    Appl Health Econ Health Policy; 2023 May; 21(3):501-510. PubMed ID: 36652186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis and Current Treatment Strategies of Hepatocellular Carcinoma.
    Tümen D; Heumann P; Gülow K; Demirci CN; Cosma LS; Müller M; Kandulski A
    Biomedicines; 2022 Dec; 10(12):. PubMed ID: 36551958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of Treatment, Cost, and Survival in Patients With Metastatic Colorectal Cancer in Western Washington, United States, and British Columbia, Canada.
    Yezefski TA; Le D; Chen L; Speers CH; Chennupati S; Snider J; Gill S; Ramsey SD; Kennecke HF; Shankaran V
    JCO Oncol Pract; 2020 May; 16(5):e425-e432. PubMed ID: 32298222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and economic consequences of reference pricing for dihydropyridine calcium channel blockers.
    Schneeweiss S; Soumerai SB; Maclure M; Dormuth C; Walker AM; Glynn RJ
    Clin Pharmacol Ther; 2003 Oct; 74(4):388-400. PubMed ID: 14534526
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States.
    Kaplan DE; Chapko MK; Mehta R; Dai F; Skanderson M; Aytaman A; Baytarian M; D'Addeo K; Fox R; Hunt K; Pocha C; Valderrama A; Taddei TH;
    Clin Gastroenterol Hepatol; 2018 Jan; 16(1):106-114.e5. PubMed ID: 28756056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Real-World Treatment Patterns, Survival, and Costs for Ovarian Cancer in Canada: A Retrospective Cohort Study Using Provincial Administrative Data.
    Hurry M; Hassan S; Seung SJ; Walton RN; Elnoursi A; McGee JD
    J Health Econ Outcomes Res; 2021; 8(2):114-121. PubMed ID: 34993257
    [No Abstract]   [Full Text] [Related]  

  • 34. Patterns of initial management of node-negative breast cancer in two Canadian provinces. British Columbia/Ontario Working Group.
    Goel V; Olivotto I; Hislop TG; Sawka C; Coldman A; Holowaty EJ
    CMAJ; 1997 Jan; 156(1):25-35. PubMed ID: 9006561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional variation in multimorbidity prevalence in British Columbia, Canada: a cross-sectional analysis of Canadian Community Health Survey data, 2015/16.
    Basham CA
    Health Promot Chronic Dis Prev Can; 2020 Aug; 40(7-8):225-234. PubMed ID: 32667879
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bibliometric study of immunotherapy for hepatocellular carcinoma.
    Li Z; Zhang Y; Zhang B; Guo R; He M; Liu ZL; Yang L; Wang H
    Front Immunol; 2023; 14():1210802. PubMed ID: 37600802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Goals and targets for personalized therapy for HCC.
    Couri T; Pillai A
    Hepatol Int; 2019 Mar; 13(2):125-137. PubMed ID: 30600478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Economic evaluations of radioembolization with Itrium-90 microspheres in hepatocellular carcinoma: a systematic review.
    Alonso JC; Casans I; González FM; Fuster D; Rodríguez A; Sánchez N; Oyagüez I; Burgos R; Williams AO; Espinoza N
    BMC Gastroenterol; 2022 Jul; 22(1):326. PubMed ID: 35780112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative net cost impact of the utilization of panitumumab versus cetuximab for the treatment of patients with metastatic colorectal cancer in Canada.
    Pettigrew M; Kavan P; Surprenant L; Lim HJ
    J Med Econ; 2016; 19(2):135-47. PubMed ID: 26442575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival characteristics of fibrolamellar hepatocellular carcinoma: A Surveillance, Epidemiology, and End Results database study.
    Sempokuya T; Forlemu A; Azawi M; Silangcruz K; Khoury N; Ma J; Wong LL
    World J Clin Oncol; 2022 May; 13(5):352-365. PubMed ID: 35662983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.